K954571

Substantially Equivalent

ABUSIGN DOA 3, DOA, COC/THC/OPI, ACCUSIGN DOA 3, BIOSIGN DOA 3, COC/THC/OOPI

Applicant: Princeton BioMeditech Corp.
Product code: DIO
Advisory panel: Clinical Toxicology
Date received: 1995-10-02
Decision date: 1995-11-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.